Your browser doesn't support javascript.
loading
Contingency Management and Pre-Exposure Prophylaxis Adherence Support Services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs.
Sung, Minhee L; Viera, Adam; Esserman, Denise; Tong, Guangyu; Davidson, Daniel; Aiudi, Sherry; Bailey, Genie L; Buchanan, Ashley L; Buchelli, Marianne; Jenkins, Mark; John, Betsey; Kolakowski, Jennifer; Lame, Albana; Murphy, Sean M; Porter, Elizabeth; Simone, Laura; Paris, Manuel; Rash, Carla J; Edelman, E Jennifer.
Affiliation
  • Sung ML; VA Connecticut Healthcare System, West Haven, CT, USA; Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. Electronic address: minhee.sung@yale.edu.
  • Viera A; Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, USA; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA.
  • Esserman D; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA.
  • Tong G; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA.
  • Davidson D; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA.
  • Aiudi S; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA.
  • Bailey GL; Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA; Stanley Street Treatment and Resources (SSTAR) Inc., Fall River, MA, USA.
  • Buchanan AL; College of Pharmacy, Department of Pharmacy Practice University of Rhode Island, South Kingston, RI, USA.
  • Buchelli M; Connecticut Department of Public Health, Hartford, CT, USA.
  • Jenkins M; Connecticut Harm Reduction Alliance, Hartford, CT, USA.
  • John B; Massachusetts Department of Public Health, Boston, MA, USA.
  • Kolakowski J; Recovery Network of Programs, Inc., Bridgeport, CT, USA.
  • Lame A; Apex Community Care, Danbury, CT, USA.
  • Murphy SM; Department of Population Health Sciences, Weill Cornell Medical College, New York, NY, USA.
  • Porter E; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Simone L; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA.
  • Paris M; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Rash CJ; UConn Health School of Medicine, Farmington, CT, USA.
  • Edelman EJ; Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, USA; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA; Department of Internal Med
Contemp Clin Trials ; 125: 107037, 2023 02.
Article in En | MEDLINE | ID: mdl-36460267
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Substance Abuse, Intravenous / Anti-HIV Agents / Drug Users / Pre-Exposure Prophylaxis Type of study: Clinical_trials / Etiology_studies / Evaluation_studies / Guideline / Prognostic_studies / Risk_factors_studies Aspects: Implementation_research Limits: Humans Language: En Journal: Contemp Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Substance Abuse, Intravenous / Anti-HIV Agents / Drug Users / Pre-Exposure Prophylaxis Type of study: Clinical_trials / Etiology_studies / Evaluation_studies / Guideline / Prognostic_studies / Risk_factors_studies Aspects: Implementation_research Limits: Humans Language: En Journal: Contemp Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2023 Document type: Article Country of publication: United States